| Year |
Citation |
Score |
| 2020 |
Morales F, Vásquez M, Corrales E, Vindas-Smith R, Santamaría-Ulloa C, Zhang B, Sirito M, Estecio MR, Krahe R, Monckton DG. Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset. Human Molecular Genetics. PMID 32601694 DOI: 10.1093/Hmg/Ddaa123 |
0.313 |
|
| 2020 |
Kurkiewicz A, Cooper A, McIlwaine E, Cumming SA, Adam B, Krahe R, Puymirat J, Schoser B, Timchenko L, Ashizawa T, Thornton CA, Rogers S, McClure JD, Monckton DG. Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial. Plos One. 15: e0231000. PMID 32287265 DOI: 10.1371/Journal.Pone.0231000 |
0.337 |
|
| 2019 |
Corrales E, Vásquez M, Zhang B, Santamaría-Ulloa C, Cuenca P, Krahe R, Monckton DG, Morales F. Analysis of mutational dynamics at the DMPK (CTG)n locus identifies saliva as a suitable DNA sample source for genetic analysis in myotonic dystrophy type 1. Plos One. 14: e0216407. PMID 31048891 DOI: 10.1371/Journal.Pone.0216407 |
0.32 |
|
| 2017 |
Yenigun VB, Sirito M, Amcheslavky A, Czernuszewicz T, Colonques-Bellmunt J, García-Alcover I, Wojciechowska M, Bolduc C, Chen Z, López Castel A, Krahe R, Bergmann A. (CCUG)n RNA toxicity in a Drosophila model for myotonic dystrophy type 2 (DM2) activates apoptosis. Disease Models & Mechanisms. PMID 28623239 DOI: 10.1242/Dmm.026179 |
0.333 |
|
| 2016 |
Chakraborty S, Vatta M, Bachinski LL, Krahe R, Dlouhy S, Bai S. Molecular Diagnosis of Myotonic Dystrophy. Current Protocols in Human Genetics. 91: 9.29.1-9.29.19. PMID 27727437 DOI: 10.1002/Cphg.22 |
0.408 |
|
| 2014 |
Screen M, Jonson PH, Raheem O, Palmio J, Laaksonen R, Lehtimäki T, Sirito M, Krahe R, Hackman P, Udd B. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions. The American Journal of Pathology. 184: 2322-32. PMID 24907641 DOI: 10.1016/J.Ajpath.2014.04.013 |
0.375 |
|
| 2014 |
Bachinski LL, Baggerly KA, Neubauer VL, Nixon TJ, Raheem O, Sirito M, Unruh AK, Zhang J, Nagarajan L, Timchenko LT, Bassez G, Eymard B, Gamez J, Ashizawa T, Mendell JR, ... ... Krahe R, et al. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscular Disorders : Nmd. 24: 227-40. PMID 24332166 DOI: 10.1016/J.Nmd.2013.11.001 |
0.373 |
|
| 2013 |
Vihola A, Sirito M, Bachinski LL, Raheem O, Screen M, Suominen T, Krahe R, Udd B. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2. Neuropathology and Applied Neurobiology. 39: 390-405. PMID 22758909 DOI: 10.1111/J.1365-2990.2012.01289.X |
0.329 |
|
| 2012 |
Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. The Lancet. Neurology. 11: 891-905. PMID 22995693 DOI: 10.1016/S1474-4422(12)70204-1 |
0.366 |
|
| 2012 |
Izaguirre DI, Zhu W, Hai T, Cheung HC, Krahe R, Cote GJ. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis. Molecular Carcinogenesis. 51: 895-906. PMID 21976412 DOI: 10.1002/Mc.20859 |
0.318 |
|
| 2011 |
Fang S, Krahe R, Bachinski LL, Zhang B, Amos CI, Strong LC. Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers. Human Genetics. 130: 789-94. PMID 21688173 DOI: 10.1007/S00439-011-1039-0 |
0.326 |
|
| 2011 |
Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, Schoser B, Moxley R. Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands. Neuromuscular Disorders : Nmd. 21: 443-50. PMID 21543227 DOI: 10.1016/J.Nmd.2011.03.013 |
0.444 |
|
| 2011 |
Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. European Journal of Human Genetics : Ejhg. 19: 776-82. PMID 21364698 DOI: 10.1038/Ejhg.2011.23 |
0.379 |
|
| 2011 |
Wu CC, Krahe R, Lozano G, Zhang B, Wilson CD, Jo EJ, Amos CI, Shete S, Strong LC. Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Human Genetics. 129: 663-73. PMID 21305319 DOI: 10.1007/S00439-011-0957-1 |
0.336 |
|
| 2010 |
Bachinski LL, Sirito M, Böhme M, Baggerly KA, Udd B, Krahe R. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders. Muscle & Nerve. 42: 856-63. PMID 21104860 DOI: 10.1002/Mus.21789 |
0.363 |
|
| 2010 |
Raheem O, Olufemi SE, Bachinski LL, Vihola A, Sirito M, Holmlund-Hampf J, Haapasalo H, Li YP, Udd B, Krahe R. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2. The American Journal of Pathology. 177: 3025-36. PMID 20971734 DOI: 10.2353/Ajpath.2010.100179 |
0.401 |
|
| 2010 |
Fang S, Krahe R, Lozano G, Han Y, Chen W, Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC, Amos CI. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. Plos One. 5: e10813. PMID 20520810 DOI: 10.1371/Journal.Pone.0010813 |
0.324 |
|
| 2010 |
Sammons MA, Antons AK, Bendjennat M, Udd B, Krahe R, Link AJ. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2. Plos One. 5: e9301. PMID 20174632 DOI: 10.1371/Journal.Pone.0009301 |
0.342 |
|
| 2010 |
Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, Baggerly KA, Raheem O, Haapasalo H, Suominen T, Holmlund-Hampf J, Paetau A, Cardani R, Meola G, Kalimo H, Edström L, ... Krahe R, et al. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathologica. 119: 465-79. PMID 20066428 DOI: 10.1007/S00401-010-0637-6 |
0.383 |
|
| 2010 |
Suominen T, Bachinski LL, Auvinen S, Hackman P, Angelini C, Peltonen L, Krahe R, Udd B. P2.32 The frequency of myotonic dystrophy type 2 (DM2) and type 1 (DM1) mutations in the population Neuromuscular Disorders. 20: 628-628. DOI: 10.1016/J.Nmd.2010.07.104 |
0.33 |
|
| 2009 |
Bachinski LL, Czernuszewicz T, Ramagli LS, Suominen T, Shriver MD, Udd B, Siciliano MJ, Krahe R. Premutation allele pool in myotonic dystrophy type 2. Neurology. 72: 490-7. PMID 19020295 DOI: 10.1212/01.Wnl.0000333665.01888.33 |
0.321 |
|
| 2008 |
Auvinen S, Suominen T, Hannonen P, Bachinski LL, Krahe R, Udd B. Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia. Arthritis and Rheumatism. 58: 3627-31. PMID 18975316 DOI: 10.1002/Art.24037 |
0.371 |
|
| 2008 |
Suominen T, Schoser B, Raheem O, Auvinen S, Walter M, Krahe R, Lochmüller H, Kress W, Udd B. High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. Journal of Neurology. 255: 1731-6. PMID 18807109 DOI: 10.1007/S00415-008-0010-Z |
0.36 |
|
| 2008 |
Cheung HC, Baggerly KA, Tsavachidis S, Bachinski LL, Neubauer VL, Nixon TJ, Aldape KD, Cote GJ, Krahe R. Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. Bmc Genomics. 9: 216. PMID 18474104 DOI: 10.1186/1471-2164-9-216 |
0.316 |
|
| 2007 |
Müller JS, Herczegfalvi A, Vilchez JJ, Colomer J, Bachinski LL, Mihaylova V, Santos M, Schara U, Deschauer M, Shevell M, Poulin C, Dias A, Soudo A, Hietala M, Aärimaa T, ... Krahe R, et al. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain : a Journal of Neurology. 130: 1497-506. PMID 17439981 DOI: 10.1093/Brain/Awm068 |
0.375 |
|
| 2007 |
Vihola A, Sirito M, Bachinski L, Olufemi S, Raheem O, Suominen T, Udd B, Krahe R. G.P.14.14 Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1) Neuromuscular Disorders. 17: 858. DOI: 10.1016/J.Nmd.2007.06.323 |
0.325 |
|
| 2006 |
Suominen T, Raheem O, Vihola A, Haapasalo H, Krahe R, Udd B. P.P.2 06 ClC1 chloride channel gene mutations in myotonic dystrophy type 2 patients Neuromuscular Disorders. 16: 672. DOI: 10.1016/J.Nmd.2006.05.100 |
0.336 |
|
| 2005 |
Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology. 65: 1636-8. PMID 16301494 DOI: 10.1212/01.Wnl.0000184585.93864.4E |
0.31 |
|
| 2005 |
Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors. Genes, Chromosomes & Cancer. 43: 172-80. PMID 15761866 DOI: 10.1002/Gcc.20169 |
0.378 |
|
| 2004 |
Van Goethem G, Luoma P, Rantamäki M, Al Memar A, Kaakkola S, Hackman P, Krahe R, Löfgren A, Martin JJ, De Jonghe P, Suomalainen A, Udd B, Van Broeckhoven C. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology. 63: 1251-7. PMID 15477547 DOI: 10.1212/01.Wnl.0000140494.58732.83 |
0.375 |
|
| 2004 |
Grewal RP, Zhang S, Ma W, Rosenberg M, Krahe R. Clinical and genetic analysis of a family with PROMM. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 11: 603-5. PMID 15261229 DOI: 10.1016/J.Jocn.2003.09.014 |
0.577 |
|
| 2004 |
Tanner SM, Li Z, Bisson R, Acar C, Oner C, Oner R, Cetin M, Abdelaal MA, Ismail EA, Lissens W, Krahe R, Broch H, Gräsbeck R, de la Chapelle A. Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East. Human Mutation. 23: 327-33. PMID 15024727 DOI: 10.1002/Humu.20014 |
0.375 |
|
| 2004 |
Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, Zhang S, Sirito M, Kalimo H, Meola G, Horelli-Kuitunen N, Wessman M, Krahe R, Udd B. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscular Disorders : Nmd. 14: 274-83. PMID 15019706 DOI: 10.1016/J.Nmd.2004.01.002 |
0.588 |
|
| 2003 |
Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscular Disorders : Nmd. 13: 813-21. PMID 14678804 DOI: 10.1016/S0960-8966(03)00137-8 |
0.515 |
|
| 2003 |
Miller BJ, Wang D, Krahe R, Wright FA. Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. American Journal of Human Genetics. 73: 748-67. PMID 13680524 DOI: 10.1086/378522 |
0.341 |
|
| 2003 |
Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, ... ... Krahe R, et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. American Journal of Human Genetics. 73: 835-48. PMID 12970845 DOI: 10.1086/378566 |
0.602 |
|
| 2003 |
Udd B, Meola G, Krahe R, Thornton C, Ranum L, Day J, Bassez G, Ricker K. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscular Disorders : Nmd. 13: 589-96. PMID 12921797 DOI: 10.1016/S0960-8966(03)00092-0 |
0.413 |
|
| 2003 |
Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology. 60: 1854-7. PMID 12796551 DOI: 10.1212/01.Wnl.0000065898.61358.09 |
0.517 |
|
| 2002 |
Lemon WJ, Palatini JJ, Krahe R, Wright FA. Theoretical and experimental comparisons of gene expression indexes for oligonucleotide arrays. Bioinformatics (Oxford, England). 18: 1470-6. PMID 12424118 DOI: 10.1093/Bioinformatics/18.11.1470 |
0.309 |
|
| 2002 |
Miano JM, Kitchen CM, Chen J, Maltby KM, Kelly LA, Weiler H, Krahe R, Ashworth LK, Garcia E. Expression of human smooth muscle calponin in transgenic mice revealed with a bacterial artificial chromosome. American Journal of Physiology. Heart and Circulatory Physiology. 282: H1793-803. PMID 11959645 DOI: 10.1152/Ajpheart.00875.2001 |
0.332 |
|
| 2002 |
Zhang S, Krahe R. Physical and transcript map of a 2-Mb region in Xp22.1 containing candidate genes for X-linked mental retardation and short stature. Genomics. 79: 274-7. PMID 11863356 DOI: 10.1006/Geno.2002.6702 |
0.532 |
|
| 2001 |
Karacay B, O'Dorisio MS, Kasow K, Hollenback C, Krahe R. Expression and fine mapping of murine vasoactive intestinal peptide receptor 1. Journal of Molecular Neuroscience : Mn. 17: 311-24. PMID 11859927 DOI: 10.1385/Jmn:17:3:311 |
0.341 |
|
| 2001 |
Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Frühwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA, Plass C. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood. 97: 3226-33. PMID 11342453 DOI: 10.1182/Blood.V97.10.3226 |
0.315 |
|
| 2001 |
Zhuo D, Zhao WD, Wright FA, Yang HY, Wang JP, Sears R, Baer T, Kwon DH, Gordon D, Gibbs S, Dai D, Yang Q, Spitzner J, Krahe R, Stredney D, et al. Assembly, annotation, and integration of UNIGENE clusters into the human genome draft. Genome Research. 11: 904-18. PMID 11337484 DOI: 10.1101/Gr.Gr-1645R |
0.303 |
|
| 2001 |
Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proceedings of the National Academy of Sciences of the United States of America. 98: 1124-9. PMID 11158605 DOI: 10.1073/Pnas.98.3.1124 |
0.339 |
|
| 2001 |
Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes, Chromosomes & Cancer. 30: 38-47. PMID 11107174 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1052>3.0.Co;2-S |
0.325 |
|
| 2001 |
Virtaneva KI, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, Chapelle Adl, Krahe R. Gene expression profiling reveals fundamental biological differences in AML with trisomy 8 and normal cytogenetics Nature Genetics. 27: 65-65. DOI: 10.1038/87158 |
0.319 |
|
| 2000 |
Wise DO, Krahe R, Oakley BR. The gamma-tubulin gene family in humans. Genomics. 67: 164-70. PMID 10903841 DOI: 10.1006/Geno.2000.6247 |
0.323 |
|
| 2000 |
Kristiansen M, Aminoff M, Jacobsen C, de La Chapelle A, Krahe R, Verroust PJ, Moestrup SK. Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor-vitamin B(12) by cubilin. Blood. 96: 405-9. PMID 10887099 DOI: 10.1182/Blood.V96.2.405.014K16_405_409 |
0.338 |
|
| 2000 |
Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, Krahe R, Kivelä T, Kucherlapati R, Forsius H, de la Chapelle A. Mutations in KERA, encoding keratocan, cause cornea plana. Nature Genetics. 25: 91-5. PMID 10802664 DOI: 10.1038/75664 |
0.39 |
|
| 2000 |
Ashizawa T, Gonzales I, Ohsawa N, Singer RH, Devillers M, Balasubramanyam A, Cooper TA, Khajavi M, Lia-Baldini AS, Miller G, Philips AV, Timchenko LT, Waring J, Yamagata H, Barbet JP, ... ... Krahe R, et al. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1) Neurology. 54: 1218-1221. PMID 10746587 DOI: 10.1212/Wnl.54.6.1218 |
0.383 |
|
| 2000 |
Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Knuutila S, Bloomfield CD, Caligiuri MA. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 97: 2145-50. PMID 10681437 DOI: 10.1073/Pnas.040569197 |
0.358 |
|
| 1999 |
Miano JM, Garcia E, Krahe R. Radiation Hybrid (RH) Mapping of Human Smooth Muscle-Restricted Genes. Methods in Molecular Medicine. 30: 25-35. PMID 21341013 DOI: 10.1385/1-59259-247-3:25 |
0.408 |
|
| 1999 |
Aminoff M, Carter JE, Chadwick RB, Johnson C, Gräsbeck R, Abdelaal MA, Broch H, Jenner LB, Verroust PJ, Moestrup SK, de la Chapelle A, Krahe R. Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nature Genetics. 21: 309-13. PMID 10080186 DOI: 10.1038/6831 |
0.362 |
|
| 1997 |
Miano JM, Krahe R, Garcia E, Elliott JM, Olson EN. Expression, genomic structure and high resolution mapping to 19p13.2 of the human smooth muscle cell calponin gene. Gene. 197: 215-24. PMID 9332369 DOI: 10.1016/S0378-1119(97)00265-5 |
0.376 |
|
| 1997 |
Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy--a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromuscular Disorders : Nmd. 7: 217-28. PMID 9196902 DOI: 10.1016/S0960-8966(97)00041-2 |
0.368 |
|
| 1997 |
Virtaneva K, D'Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G, Franceschetti S, Michelucci R, Tassinari CA, Omer S, Pennacchio LA, Myers RM, Dieguez-Lucena JL, Krahe R, de la Chapelle A, et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nature Genetics. 15: 393-6. PMID 9090386 DOI: 10.1038/Ng0497-393 |
0.429 |
|
| 1997 |
Bachinski LL, Abchee A, Durand JB, Roberts R, Krahe R, Hobson GM. Polymorphic trinucleotide repeat in the MEF2A gene at 15q26 is not expanded in familial cardiomyopathies. Molecular and Cellular Probes. 11: 55-8. PMID 9076715 DOI: 10.1006/Mcpr.1996.0076 |
0.347 |
|
| 1996 |
Abbruzzese C, Krahe R, Liguori M, Tessarolo D, Siciliano MJ, Ashizawa T, Giacanelli M. Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)? Journal of Neurology. 243: 715-21. PMID 8923304 DOI: 10.1007/Bf00873977 |
0.409 |
|
| 1995 |
Boucher CA, King SK, Carey N, Krahe R, Winchester CL, Rahman S, Creavin T, Meghji P, Bailey ME, Chartier FL. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Human Molecular Genetics. 4: 1919-25. PMID 8595416 DOI: 10.1093/Hmg/4.10.1919 |
0.405 |
|
| 1995 |
Hobson GM, Krahe R, Garcia E, Siciliano MJ, Funanage VL. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23. Genomics. 29: 704-11. PMID 8575763 DOI: 10.1006/Geno.1995.9007 |
0.374 |
|
| 1995 |
Krahe R, Ashizawa T, Abbruzzese C, Roeder E, Carango P, Giacanelli M, Funanage VL, Siciliano MJ. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics. 28: 1-14. PMID 7590731 DOI: 10.1006/Geno.1995.1099 |
0.366 |
|
| Show low-probability matches. |